Hossein Zargartalebi

Hossein Zargartalebi

Auto-generated profile, based on publicly available information

Hossein Zargartalebi

Department of Biomedical Engineering, McCormick School of Engineering, Northwestern University, Evanston, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2024 in Science
Verified
Journal Article
Closed access
HZH. Zargartalebi
H. Zargartalebi
Sako MirzaieSako Mirzaie
Sako Mirzaie
ANAmin Ghavami Nejad
Amin Ghavami Nejad
SAS. U. Ahmed
S. U. Ahmed
FEF. Esmaeili
F. Esmaeili
SKS. O. Kelley
S. O. Kelley
Continuous measurement of proteins in vivo is important for real-time disease management and prevention. Implantable sensors for monitoring small molecules such as glucose have been available for more than a decade. However, analysis of proteins remains an unmet need because the lower physiological levels require that sensors have high affinities, which are linked to long complexation half-lives ( t 1/2 ~20 hours) and slow equilibration when concentrations decrease. We report active-reset sensors by use of high-frequency oscillations to accelerate dissociation, which enables regeneration of the unbound form of the sensor within 1 minute. When implemented within implanted devices, these sensors allow for real-time, in vivo monitoring of proteins within interstitial fluid. Active-reset protein sensors track biomarker levels on a physiological timescale for inflammation monitoring in living animals.

7 August 2025 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
AGAmin GhavamiNejad
Amin GhavamiNejad
CFConnor D. Flynn
Connor D. Flynn
AGArmin Geraili
Armin Geraili
SMSako Mirzaie
Sako Mirzaie
FEFatemeh Esmaeili
Fatemeh Esmaeili
SKShana O. Kelley
Shana O. Kelley

30 July 2024 in ACS Nano
Verified
Journal Article
Closed access
FEFatemeh Esmaeili
Fatemeh Esmaeili
YWYuhao Leo Wu
Yuhao Leo Wu
ZWZongjie Wang
Zongjie Wang
AAAbdalla Abdrabou
Abdalla Abdrabou
VJVuslat B. Juska
Vuslat B. Juska
SKShana O. Kelley
Shana O. Kelley

29 November 2024 in Science Advances
Verified
Journal Article
Open access
AAAbdalla M. Abdrabou
Abdalla M. Abdrabou
SASharif U. Ahmed
Sharif U. Ahmed
MFMengqi Jonathan Fan
Mengqi Jonathan Fan
BDBill T. V. Duong
Bill T. V. Duong
Kangfu ChenKangfu Chen
Kangfu Chen
SKShana O. Kelley
Shana O. Kelley
Numerous human cancers have exhibited the ability to elude immune checkpoint blockade (ICB) therapies. This type of resistance can be mediated by immune-suppressive macrophages that limit antitumor immunity in the tumor microenvironment (TME). Here, we elucidate a strategy to shift macrophages into a proinflammatory state that down-regulates V domain immunoglobulin suppressor of T cell activation (VISTA) via inhibiting AhR and IRAK1. We used a high-throughput microfluidic platform combined with a genome-wide CRISPR knockout screen to identify regulators of VISTA levels. Functional characterization showed that the knockdown of these hits diminished VISTA surface levels on macrophages and sustained an antitumor phenotype. Furthermore, targeting of both AhR and IRAK1 in mouse models overcame resistance to ICB treatment. Tumor immunophenotyping indicated that infiltration of cytotoxic CD8 + cells, natural killer cells, and antitumor macrophages was substantially increased in treated mice. Collectively, AhR and IRAK1 are implicated as regulators of VISTA that coordinate a multifaceted barrier to antitumor immune responses.